graft-versus-host disease


Also found in: Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to graft-versus-host disease: cGVHD

graft-ver·sus-host disease

(grăft′vûr′səs-hōst′, -səz-)
n.
A condition in which cells from the transplanted tissue of a donor initiate an immunologic attack on the cells and tissue of the recipient.

graft′-ver`sus-host′ disease`


n.
a reaction in which the cells of transplanted tissue immunologically attack the cells of the host.
Mentioned in ?
References in periodicals archive ?
Bone marrow transplants from partially matched donors carry about an 80 percent risk of graft-versus-host disease and the myxoma treatment would address that,' Cogle added.
M2 EQUITYBITES-July 24, 2017-Incyte treats first patient in graft-versus-host disease trial
M2 PHARMA-July 24, 2017-Incyte treats first patient in graft-versus-host disease trial
The trial will test the safety and efficacy of CYP-001 in patients with steroid-resistant graft-versus-host disease (GvHD).
NASDAQ: INCY) has acquired the rights to develop and commercialise ruxolitinib (Jakafi), its proprietary JAK1/JAK2 inhibitor, for graft-versus-host disease from US-based pharmaceutical company Eli Lilly and Co.
However once received, as many as half of these allogenic transplant recipients experiences a post-transplant complication known as Graft-versus-host disease (GVHD).
A 61-year-old man with a history of acute myeloid leukemia, stem cell transplant, and graft-versus-host disease (GVHD) presented with solid food dysphagia.
The occurrence of an immunologically mediated and injurious set of reactions by cells genetically disparate to their host, otherwise known as graft-versus-host disease (GVHD), is a phenomenon that has been described as the age of bone marrow and solid organ transplantation has emerged.
Unfortunately, immune cells from these new arrivals can run amok in the recipient, creating a life-threatening complication called graft-versus-host disease (GVHD).
Five days after cessation of the iHg injections, both case and control mice were intravenously administered spleen cells from another mouse strain to induce chronic graft-versus-host disease (GVHD), a well-established murine model of acquired autoimmunity.
Graft-versus-host disease, the most severe complication from the combined regimen is "a double-edged sword since we're depending on the graft-versus-host reaction to provide the graft-versus-myeloma effect," Dr.
Biohybrid's product platform of hybrid antibodies and genetically engineered vectors are agents for the treatment of graft rejection, graft-versus-host disease, and autoimmune disorders.